Ken Griffin's position in CureVac N.V. is currently worth $3.41 Million. That's 0.00% of their equity portfolio (1876th largest holding). The first CureVac N.V. trade was made in Q1 2021. Since then Ken Griffin bought shares seven more times and sold shares on five occasions. The investor's estimated purchase price is $9.46 Million, resulting in a loss of 64%.